These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19834714)
1. Arsenic exposure predicts bladder cancer survival in a US population. Kwong RC; Karagas MR; Kelsey KT; Mason RA; Tanyos SA; Schned AR; Marsit CJ; Andrew AS World J Urol; 2010 Aug; 28(4):487-92. PubMed ID: 19834714 [TBL] [Abstract][Full Text] [Related]
2. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537 [TBL] [Abstract][Full Text] [Related]
3. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water. Cottingham KL; Karimi R; Gruber JF; Zens MS; Sayarath V; Folt CL; Punshon T; Morris JS; Karagas MR Nutr J; 2013 Nov; 12():149. PubMed ID: 24237880 [TBL] [Abstract][Full Text] [Related]
4. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Karagas MR; Stukel TA; Morris JS; Tosteson TD; Weiss JE; Spencer SK; Greenberg ER Am J Epidemiol; 2001 Mar; 153(6):559-65. PubMed ID: 11257063 [TBL] [Abstract][Full Text] [Related]
5. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Karagas MR; Stukel TA; Tosteson TD Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020 [TBL] [Abstract][Full Text] [Related]
6. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466 [TBL] [Abstract][Full Text] [Related]
7. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Karagas MR; Tosteson TD; Blum J; Morris JS; Baron JA; Klaue B Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491 [TBL] [Abstract][Full Text] [Related]
8. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA. Slotnick MJ; Meliker JR; Nriagu JO J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735 [TBL] [Abstract][Full Text] [Related]
9. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. Baris D; Waddell R; Beane Freeman LE; Schwenn M; Colt JS; Ayotte JD; Ward MH; Nuckols J; Schned A; Jackson B; Clerkin C; Rothman N; Moore LE; Taylor A; Robinson G; Hosain GM; Armenti KR; McCoy R; Samanic C; Hoover RN; Fraumeni JF; Johnson A; Karagas MR; Silverman DT J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27140955 [TBL] [Abstract][Full Text] [Related]
10. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543 [TBL] [Abstract][Full Text] [Related]
11. Associations between toenail arsenic concentration and dietary factors in a New Hampshire population. Gruber JF; Karagas MR; Gilbert-Diamond D; Bagley PJ; Zens MS; Sayarath V; Punshon T; Morris JS; Cottingham KL Nutr J; 2012 Jun; 11():45. PubMed ID: 22747713 [TBL] [Abstract][Full Text] [Related]
12. Lung cancer in a U.S. population with low to moderate arsenic exposure. Heck JE; Andrew AS; Onega T; Rigas JR; Jackson BP; Karagas MR; Duell EJ Environ Health Perspect; 2009 Nov; 117(11):1718-23. PubMed ID: 20049123 [TBL] [Abstract][Full Text] [Related]
13. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Andrew AS; Karagas MR; Hamilton JW Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548 [TBL] [Abstract][Full Text] [Related]
14. Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study. Farzan SF; Chen Y; Rees JR; Zens MS; Karagas MR Toxicol Appl Pharmacol; 2015 Sep; 287(2):93-97. PubMed ID: 26048586 [TBL] [Abstract][Full Text] [Related]
15. Case-control study of bladder cancer and exposure to arsenic in Argentina. Bates MN; Rey OA; Biggs ML; Hopenhayn C; Moore LE; Kalman D; Steinmaus C; Smith AH Am J Epidemiol; 2004 Feb; 159(4):381-9. PubMed ID: 14769642 [TBL] [Abstract][Full Text] [Related]
16. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Andrew AS; Mason RA; Kelsey KT; Schned AR; Marsit CJ; Nelson HH; Karagas MR Toxicol Lett; 2009 May; 187(1):10-4. PubMed ID: 19429237 [TBL] [Abstract][Full Text] [Related]
17. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Karagas MR; Le CX; Morris S; Blum J; Lu X; Spate V; Carey M; Stannard V; Klaue B; Tosteson TD Int J Occup Med Environ Health; 2001; 14(2):171-5. PubMed ID: 11548067 [TBL] [Abstract][Full Text] [Related]
18. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Karagas MR; Tosteson TD; Blum J; Klaue B; Weiss JE; Stannard V; Spate V; Morris JS Am J Epidemiol; 2000 Jul; 152(1):84-90. PubMed ID: 10901333 [TBL] [Abstract][Full Text] [Related]
19. Estimating water supply arsenic levels in the New England Bladder Cancer Study. Nuckols JR; Freeman LE; Lubin JH; Airola MS; Baris D; Ayotte JD; Taylor A; Paulu C; Karagas MR; Colt J; Ward MH; Huang AT; Bress W; Cherala S; Silverman DT; Cantor KP Environ Health Perspect; 2011 Sep; 119(9):1279-85. PubMed ID: 21421449 [TBL] [Abstract][Full Text] [Related]
20. Geostatistical modelling of arsenic in drinking water wells and related toenail arsenic concentrations across Nova Scotia, Canada. Dummer TJ; Yu ZM; Nauta L; Murimboh JD; Parker L Sci Total Environ; 2015 Feb; 505():1248-58. PubMed ID: 24613511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]